Latest in FAIM
iiiiiiiii
April 1, 2022
AI company that aims to enhance human capabilities; they believe AI can significantly assist any task and enable healthcare to keep doing more with less...
April 1, 2022
Artificial intelligence , and machine learning are rapidly changing the study of cancer immunology, harboring great implications for the future of cancer treatment...
April 1, 2022
Sweden has a highly export-oriented economy that is always open for opportunities. A.I technology is one of the main industries that Sweden is trying to develop...
April 1, 2022
Alibaba, is venturing uncharted territory and taking the lead in building an AI-led future. From Cyber-Cities to cancer treatment, their projects are endless...
April 1, 2022
Big Data refers to vast and unique data sets that are changing the frontiers of many practices; healthcare is no exception...
April 1, 2022
The FDA continues to expand its authorizations of AI in medicine, from a super powerful MRI scanner to a prescription smartwatch App...
April 1, 2022
DFree® is a wearable device that predicts urination timing for people with urinary incontinence and therefore enables independence...
April 1, 2022
The years between 1956 and 1959 were a revolutionizing period of AI, with many pioneers of the field adding significant contributions...
March 1, 2022
Unsupervised learning is a potent tool that can predict data sets' insights, decisions, and results without pre-set rules...
Expert Interview
Dr. Sameer Mehta
Editor-In Chief & Founder
Sameer Mehta, MD, FACC, MBA, is a U.S. interventional cardiologist
Journal Club
Development and Validation of a Deep Learning Algorithm for Gleason Grading of Prostate Cancer from Biopsy Specimens
JAMA Network Open – Oncology – May 13, 2020
SIGN UP FOR OUR NEWSLETTER
Join our subscribers list to get the latest news and updates directly in your inbox.
From Our Book
